Autopsy report · NCT01910844
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes
Cause of deathSlow enrollment
“Because of difficulties in recruting”
Life of this trial
- Registered 2 months before it started.
- Ran for about 3 years 2 months before it stopped.
- 3 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Centre Jean Perrin
- Sponsor type
- University, hospital or other
- Conditions
- Metastatic Breast Cancer
- Interventions
- Cisplatin; Cyclophosphamide
- Participants
- 3
- Sites
- 1
- Countries
- France
Trials that died the same way
- Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors
“Due to strategic reasons” - Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes
“Because of difficulties in recruiting” - Embrace and Quality of Life
“because of technical issues” - Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients
“difficulty of recrutement” - Safe and Effective Sedation in Chronic Alcoholic Patients Underwent Diagnostic Endoscopic Procedures: Study Comparing Midazolam and Propofol With Midazolam
“because of difficulties for participants enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.